Detection of choriocarcinoma in the lung by FDG positron emission tomography

Hongming Zhuang, Alvin J. Yamamoto, Nasrin Ghesani, Abass Alavi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used successfully to detect and stage various malignant conditions, notably lung and colorectal cancers, lymphoma, and melanoma. However, not all malignancies can be detected effectively by FDG PET. To our knowledge, the detection of choriocarcinoma by FDG PET has never been reported in the literature. The authors show FDG PET effectively detected choriocarcinoma in the lung of a 29-year-old woman.

Original languageEnglish (US)
Number of pages1
JournalClinical nuclear medicine
Volume26
Issue number8
DOIs
StatePublished - Jul 31 2001

Fingerprint

Choriocarcinoma
Positron-Emission Tomography
Lung
Colorectal Neoplasms
Melanoma
Lymphoma
Lung Neoplasms
Neoplasms

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Keywords

  • Choriocarcinoma
  • Fluorodeoxyglucose
  • Positron Emission Tomography

Cite this

Zhuang, Hongming ; Yamamoto, Alvin J. ; Ghesani, Nasrin ; Alavi, Abass. / Detection of choriocarcinoma in the lung by FDG positron emission tomography. In: Clinical nuclear medicine. 2001 ; Vol. 26, No. 8.
@article{ccbe959e38af466aa56b59ac3e0f5c3e,
title = "Detection of choriocarcinoma in the lung by FDG positron emission tomography",
abstract = "Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used successfully to detect and stage various malignant conditions, notably lung and colorectal cancers, lymphoma, and melanoma. However, not all malignancies can be detected effectively by FDG PET. To our knowledge, the detection of choriocarcinoma by FDG PET has never been reported in the literature. The authors show FDG PET effectively detected choriocarcinoma in the lung of a 29-year-old woman.",
keywords = "Choriocarcinoma, Fluorodeoxyglucose, Positron Emission Tomography",
author = "Hongming Zhuang and Yamamoto, {Alvin J.} and Nasrin Ghesani and Abass Alavi",
year = "2001",
month = "7",
day = "31",
doi = "10.1097/00003072-200108000-00020",
language = "English (US)",
volume = "26",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

Detection of choriocarcinoma in the lung by FDG positron emission tomography. / Zhuang, Hongming; Yamamoto, Alvin J.; Ghesani, Nasrin; Alavi, Abass.

In: Clinical nuclear medicine, Vol. 26, No. 8, 31.07.2001.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Detection of choriocarcinoma in the lung by FDG positron emission tomography

AU - Zhuang, Hongming

AU - Yamamoto, Alvin J.

AU - Ghesani, Nasrin

AU - Alavi, Abass

PY - 2001/7/31

Y1 - 2001/7/31

N2 - Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used successfully to detect and stage various malignant conditions, notably lung and colorectal cancers, lymphoma, and melanoma. However, not all malignancies can be detected effectively by FDG PET. To our knowledge, the detection of choriocarcinoma by FDG PET has never been reported in the literature. The authors show FDG PET effectively detected choriocarcinoma in the lung of a 29-year-old woman.

AB - Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used successfully to detect and stage various malignant conditions, notably lung and colorectal cancers, lymphoma, and melanoma. However, not all malignancies can be detected effectively by FDG PET. To our knowledge, the detection of choriocarcinoma by FDG PET has never been reported in the literature. The authors show FDG PET effectively detected choriocarcinoma in the lung of a 29-year-old woman.

KW - Choriocarcinoma

KW - Fluorodeoxyglucose

KW - Positron Emission Tomography

UR - http://www.scopus.com/inward/record.url?scp=0034924075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034924075&partnerID=8YFLogxK

U2 - 10.1097/00003072-200108000-00020

DO - 10.1097/00003072-200108000-00020

M3 - Article

C2 - 11452190

AN - SCOPUS:0034924075

VL - 26

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 8

ER -